Brand Name

VIZZ

Generic Name
Aceclidine
View Brand Information
FDA approval date: July 31, 2025
Classification: Cholinergic Receptor Agonist
Form: Solution

What is VIZZ (Aceclidine)?

VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults .

Approved To Treat

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

There is no clinical trials being done for this treatment